This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
The Defense Logistics Agency (DLA) awarded a $4,711.62 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of PROQUAD VIALS. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,601.99 firm fixed price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a $6,683.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has an ultimate completion date of June 20, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, that provides a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for PROQUAD VIALS, a medical supply, with a firm fixed price ceiling value of $1,601.99. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a $5,015.10 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a period of performance through September 11, 2024. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,601.99 firm-fixed-price delivery order is for the supply of PROQUAD VIALS, a type of medical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PROQUAD VIALS to the Defense Logistics Agency (DLA). The $2,686.44 firm fixed-price delivery order has a completion date of July 10, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a firm fixed price of $6,683.60 and a period of performance through May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December...